Searched for
DEEPAK REDDY
Asian Games 2026: India eyes record medal haul in Aichi-NagoyaIndia aims for a record-breaking performance at the Aichi-Nagoya Asian Games 2026. The contingent includes five individual Olympic medallis...
BJP announces new national office-bearers team under President Nitin Nabin; Smriti Irani, Piyush Goyal among key names, check full listThe Bharatiya Janata Party has announced its new national office-bearers team. Several new faces have been assigned key organisational resp...
Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
Cockroach Janta Party unveils national team, Abhijeet Dipke named convener, check full listThe Cockroach Janta Party has announced its new national leadership team. Abhijeet Dipke will serve as the National Convener for the youth-...
Deepak Reddy takes charge as new CEO of Manappuram Finance Ltd.Manappuram Finance Limited announced the appointment of Deepak Reddy as the new Chief Executive Officer, effective August 1, 2025. Former M...
F&O outliers: September seasonality weighs on ICICI Bank, Adani Ports, TVS Motors, 7 others. Here's whyOver the last decade, five F&O stocks showed positive seasonality in September with average returns over 5%, including TVS Motor, Deepak Ni...
TDP MP may go scot-free, thanks to caste equationsAccording to TDP sources, in his Saturday meeting with party leaders, Naidu would discuss recent events where the party's image had got a b...
- Dr. Reddy’s Labs is a buy: Deepak Mohoni
Dr. Reddy’s Labs is a buy with a stop loss of Rs 1880 and target of Rs 1987, short term trade.
- Dr. Reddy’s could be very good long term investments: Deepak Mohoni
"There is a buy on Dr. Reddy’s. Dr. Reddy’s could be very good long term investments. I suspect the local pharma local majors may be on the...
- Buy Dr Reddy’s Labs and HPCL: Deepak Mohoni
Two buys, Dr. Reddy’s Labs and HPCL, both should be good intraday but could be good for swing traders as well.
- Bullish on Merck: Deepak Mohoni
Tata Chemicals, Divi’s and Merck are in very decent uptrends and they did not react too negatively during this nine-day losing streak we ha...
- Dr. Reddy's a stock worth to buy: Deepak Mohoni
It is a bit of a surprise because the stock was in a very decent uptrend and is generally speaking a fairly defensive stock.
- Bullish on Dr Reddy's: Deepak Mohoni
It has picked up fair amount of momentum lately, has made slightly better moves but overall this rally is not boosting pharma very much.
- Dr. Reddy's a buy: Deepak Mohoni
Dr. Reddy’s has been pretty strong for a while now. It is pretty safe for a good long-term bet.
- Can expect a good upside from Dr. Reddy’s: Deepak Mohoni
Dr. Reddy’s still remains a very good long-term idea.
- Dr Reddy's not in demand: Deepak Mohoni
Dr Reddy's has gone a little quite or declining slightly.
- Dr Reddy’s up with market; Ranbaxy trying to revive
Dr Reddy’s is going up with the market. It is not outperforming the Nifty.